sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Electroceuticals/Bioelectric Medicine Market Size Study, by Product, by Device Type, by Application, by End User, and Regional Forecasts 2022-2032

Global Electroceuticals/Bioelectric Medicine Market Size Study, by Product, by Device...

Home / Categories / Healthcare
Global Electroceuticals/Bioelectric Medicine Market Size Study, by Product, by Device Type, by Application, by End User, and Regional Forecasts 2022-2032
Global Electroceuticals/Bioelectric Medicine Market Size...
Report Code
RO1/103/2884

Publish Date
22/Aug/2024

Pages
200
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
The Global Electroceuticals/Bioelectric Medicine Market is valued at approximately USD 21.27 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.47% over the forecast period 2024-2032. Electroceuticals, which leverage electrical impulses to modulate neural circuits, tissues, or organs for therapeutic purposes, are increasingly gaining traction as innovative solutions for various medical conditions. This non-pharmacological approach offers promising treatments for chronic pain, neurological disorders, and psychiatric conditions, thus driving market growth. The growing geriatric population, projected to reach 1.4 billion people aged 60 and over by 2030 according to the World Health Organization (WHO), is a pivotal driver of the electroceuticals market. This demographic shift highlights the increasing prevalence of cardiovascular disorders and Parkinson's disease, necessitating advanced therapeutic technologies such as electroceuticals.

The market is also witnessing significant product innovation and regulatory support, fostering the availability of advanced electroceutical devices. For instance, the FDA approvals for Medtronic Plc's Micra AV and Boston Scientific's WaveWriter Alpha portfolio underscore the advancements in the field, bolstering market confidence and adoption. Additionally, the rise in minimally invasive procedures, government initiatives for medical device development, and advancements in healthcare technology further propel market growth. However, competition from pharmaceuticals and limited reimbursement policies pose challenges to market growth. Strategic positioning, advocating for improved reimbursement, and demonstrating cost-effectiveness are essential to overcoming these obstacles.

The key regions considered for the global electroceuticals/Bioelectric Medicine market study include North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the market in 2022, attributed to well-established healthcare infrastructure, high healthcare spending, and extensive adoption of advanced therapeutic technologies. The region has a significant patient population suffering from chronic diseases such as cardiovascular disorders, neurological conditions, and chronic pain, which drive the demand for electroceutical therapies. Moreover, North America is home to numerous leading biotechnology and medical device companies that are actively involved in the research, development, and commercialization of electroceutical devices. Asia-Pacific is expected to exhibit the fastest growth during the forecast period, driven by robust economic development, expanding population, and improving healthcare infrastructure.

Major market players included in this report are:
Boston Scientific Corporation
Medtronic Plc
LivaNova PLC
Abbott Laboratories
Cochlear Limited
Biotronik SE & Co. KG
Nevro Corp.
Second Sight Medical Products, Inc.
Inspire Medical Systems, Inc.
ElectroCore, Inc.
MicroPort Scientific Corporation
NeuroPace, Inc.
Nuvectra Corporation
Axonics Modulation Technologies, Inc.
Mainstay Medical International plc
The detailed segments and sub-segment of the market are explained below:
By Product:
Cardiac Pacemakers & Implantable Cardioverter Defibrillators
Cochlear Implants
Spinal Cord Stimulators
Deep Brain Stimulators
Vagus Nerve Stimulators
Sacral Nerve Stimulators
Others
By Device Type:
Implantable Devices
Non-invasive Devices
By Application:
Arrhythmia
Sensorineural Hearing Loss
Epilepsy
Parkinson's Disease
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLATAM
Middle East & Africa
South Africa
Saudi Arabia
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com